Page 110 - Neuropsychiatric.indd

45. St Louis EK, Gidal BE, Henry TR, Kaydanova Y, Krumholz A, McCabe PH, et al. Conversions 60. Li BD, Bi ZY, Liu JF, Si WJ, Shi QQ, Xue LP, et al. Adverse effects produced by different
between monotherapies in epilepsy: expert consensus. Epilepsy Behav. 2007;11(2):222- drugs used in the treatment of Parkinson's disease: A mixed treatment comparison. CNS

34. Neurosci Ther. 2017;23(10):827-42.
46. Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol. 61. Liu L, Jia L, Jian P, Zhou Y, Zhou J, Wu F, et al. The effects of benzodiazepine use and
2014;77(2):295-301. abuse on cognition in the elders: a systematic review and meta-analysis of comparative
47. Baclofen. [accessed 10 January 2021]. Available from: https://reference.medscape.com/ studies. Front Psychiatry. 2020;11:00755.

drug/lioresal-baclofen-343335 62. Pieper NT, Grossi CM, Chan WY, Loke YK, Savva GM, Haroulis C, et al. Anticholinergic drugs
48. Khoury R, Ghossoub E. Antipsychotics and seizures: What are the risks? Current Psychiatry. and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
2019;18(3):21-33. Age Ageing. 2020;49(6):939-47.

49. Wong J, Delva N. Clozapine-induced seizures: recognition and treatment. Can J Psychiatry. 63. Wongpakaran N, Wongpakaran T, Bookamana P, Pinyopornpanish M, Maneeton B,
2007;52(7):457-63. Lerttrakarnnon P, et al. Diagnosing delirium in elderly Thai patients: utilization of the CAM
50. Bora I, Demir AB, Uzun P. Nonconvulsive status epilepticus cases arising in connection with algorithm. BMC Fam Pract. 2011;12(1):65.
cephalosporins. Epilepsy Behav Case Rep. 2016;20(6):23-7. 64. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the
51. Krzeminski P, Lesiak A, Narbutt J. Seizures as a rare adverse effect of chloroquine therapy confusion assessment method. A new method for detection of delirium. Ann Intern Med

in systemic lupus erythematosus patients: a case report and literature survey. Postepy 1990;113(12):941-8.
Dermatol Alergol. 2018;35(4):429-30. 65. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and
52. McDonald WM. Overview of neurocognitive disorders. Focus (Am Psychiatr Publ). treatment. Nat Rev Neurol 2009;5(4):210-20.

2017;15(1):4-12. 66. สถาบันประสาทวิทยา กรมการแพทย์. แนวทางเวชปฏิบัติภาวะสมองเสื่อม. กรุงเทพมหานคร: บริษัท ธนา
53. Splinter MY. Chapter 17 Cognitive disorder. In: Tisdale JE et al., eds. Drug-Induced Diseases: เพลส จ ากัด, 2557.
Prevention, Detection, and Management. 3rd ed. United States: American Society of 67. MarxreiterีF,ีWinklerีJ,ีUhlีM,ีMadžarีD.ีAีCaseีreportีofีsevereีdeliriumีafterีamantadineี
Health-System Pharmacists, Inc., 2018. withdrawal. Case Rep Neurol. 2017;9(1):44-48.

54. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, 68. Dautzenberg L, Jessurum N, Dautzenberg PL, Keijsers CJ. Reversible methotrexate-induced
prevention and management. Drug Saf. 1999;21(2):101-22. dementia: A case report. J Am Geriatr Soc. 2015;63(6):1273-4.
55. Fuller MA. Chapter 15 Delirium. In: Tisdale JE et al., eds. Drug-Induced Diseases: Prevention, 69. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The
Detection, and Management. 3rd ed. United States: American Society of Health-System Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Pharmacists, Inc., 2018. J Am Geriatr Soc. 2005;53(4):695-9.
56. Stoner SC. Drug induced cognitive dysfunction. Medical update for psychiatrists. 1997; 70. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the
2(3):81-5. cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
57. Bowen JD, Larson EB. Drug-induced cognitive impairment. Defining the problem and finding 71. Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists.

solutions. Drugs Aging 1993;3(4):349-57. Neurohospitalist. 2011;1(1):41-7.
58. Baldez DP, Biazus TB, Rabelo-da-Ponte FD, Nogaro GP, Martins DS, Kunz M, et al. The effect 72. สุพพตา เมธารักษ์ชีพ, อรอนงค์โพธิ์แก้ววรางกูล, รุ่งโรจน์ พทยศิริ. ภาวะฉุกเฉินในกลุ่มอาการเคลื่อนไหว
ิ
of antipsychotics on the cognitive performance of individuals with psychotic disorders: ผิดปกติ. ใน กมล แก้วกิติณรงค์ และคณะ, บรรณาธิการ. Comprehensive review in internal
network meta-analyses of randomized controlled trials. Neurosci Biobehav Rev. medicine. กรุงเทพมหานคร: บริษัท ปริ้นท์แอนด์มอร์ จ ากัด, 2563.

2021;126:265-75. 73. สมาคมพิษวิทยาคลินิก. ยาต้านพิษ ๔. สมุทรปราการ: บริษัท สแกน แอนด์ พริ้นท์ จ ากัด, 2557.
59. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive 74. Rajan S, Kaas B, Moukheiber E. Movement disorders emergencies. Semin Neurol.
performance: a meta-analysis. J Clin Psychiatry. 2009;70(11):1588-97. 2019;39(1):125-36.
75. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th

edition (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

88 89
89